Loading...
OTCM
BBBT
Market cap98kUSD
Nov 03, Last price  
0.00USD
Name

Black Bird Biotech Inc

Chart & Performance

D1W1MN
OTCM:BBBT chart
P/E
P/S
1.19
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
83k
-20.96%
000691,6001,116,880000000017,77157,604104,45882,563
Net income
-2m
L-3.22%
-36,063-23,253-168,723-8,272,310-160,159-86,515-89,991-99,519-112,470-106,268-110,014-121,110-163,628-691,570-2,096,629-2,029,199
CFO
-1m
L+4.05%
-691,236-35,963-23,128-159,948-731,018167,821-67,166-78,481-81,556-80,173-77,942-75,690-76,098-86,325-619,465-992,428-1,032,574

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer gel and spray products under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program. The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021. Black Bird Biotech, Inc. is based in Flower Mound, Texas.
IPO date
Dec 10, 2007
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT